Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Maine Medical Center
mi
from
Portland, ME
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Maine Medical Center
mi
from
Portland, ME
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Maryland School of Medicine
mi
from
Baltimore, MD
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Maryland School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
mi
from
Boston, MA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Pulmonary Critical Care Medicine, Brigham and Women's Hospital
mi
from
Boston, MA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Pulmonary Critical Care Medicine, Brigham and Women's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Nebraska Medical Center
mi
from
Omaha, NE
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Nebraska Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Newark Beth Israel Medical Center
mi
from
Newark, NJ
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Winthrop University Hospital
mi
from
Mineola, NY
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Columbia Presbyterian Med Ctr
mi
from
New York, NY
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Mary M Parkes Center for Asthma, Allergy and Pulmonary Care
mi
from
Rochester, NY
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Mary M Parkes Center for Asthma, Allergy and Pulmonary Care
mi
from
Rochester, NY
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
The Lindner Research Center
mi
from
Cincinnati, OH
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
The Lindner Research Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University Hospitals of Cleveland
mi
from
Cleveland, OH
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Toledo
mi
from
Toledo, OH
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Toledo
mi
from
Toledo, OH
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Legacy Clinic Northwest
mi
from
Portland, OR
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Legacy Clinic Northwest
mi
from
Portland, OR
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Allegheny General Hospital
mi
from
Pittsburgh, PA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Pittsburg Medical Center
mi
from
Pittsburgh, PA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Pittsburg Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern
mi
from
Dallas, TX
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine, Pulmonary & Critical Care
mi
from
Houston, TX
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine, Pulmonary & Critical Care
mi
from
Houston, TX
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Inova Fairfax Hospital
mi
from
Falls Church, VA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Inova Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Aurora Health Care
mi
from
Milwaukee, WI
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Aurora Health Care
mi
from
Milwaukee, WI
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Washington University Hospital
mi
from
Saint Louis, MO
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Washington University Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
The Prince Charles Hospital
mi
from
Chermside West,
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
An Open-Label Extension Trial of UT-15C SR in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
The Prince Charles Hospital
mi
from
Chermside West,
Click here to add this to my saved trials
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Arizona Clinical and Translational Science (CATS) Research Center
mi
from
Tucson, AZ
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Arizona Clinical and Translational Science (CATS) Research Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University of California San Diego Medical Center (La Jolla)
mi
from
La Jolla, CA
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of California San Diego Medical Center (La Jolla)
mi
from
La Jolla, CA
Click here to add this to my saved trials
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
GLVA Healthcare Center
mi
from
Los Angeles, CA
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
GLVA Healthcare Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University of California, Davis, UC Davis Medical Center
mi
from
Sacramento, CA
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of California, Davis, UC Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
LIU Center for Pulmonary Hypertension
mi
from
Torrance, CA
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
LIU Center for Pulmonary Hypertension
mi
from
Torrance, CA
Click here to add this to my saved trials
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Emory University School of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine
mi
from
Atlanta, GA
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Emory University School of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Kentuckiana Pulmonary Associates
mi
from
Louisville, KY
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Kentuckiana Pulmonary Associates
mi
from
Louisville, KY
Click here to add this to my saved trials
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
LSU Health Science Center - New Orleans
mi
from
New Orleans, LA
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
LSU Health Science Center - New Orleans
mi
from
New Orleans, LA
Click here to add this to my saved trials
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
mi
from
Boston, MA
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Boston University School of Medicine / Boston University Medical Center
mi
from
Boston, MA
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Boston University School of Medicine / Boston University Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Newark Beth Israel Medical Center
mi
from
Newark, NJ
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Click here to add this to my saved trials
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center, Pediatric Cardiology
mi
from
New York, NY
ACT-293987 in Pulmonary Arterial Hypertension
Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of Selexipag (ACT-293987) in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center, Pediatric Cardiology
mi
from
New York, NY
Click here to add this to my saved trials